Janssen
is a New Jersey-based pharmaceutical firm that researches and develops medicinal products for the treatment of oncology, cardiovascular and immunology... Read moreJanssen
is a New Jersey-based pharmaceutical firm that researches and develops medicinal products for the treatment of oncology, cardiovascular and immunology... Read more
News
Mar 08, 2025
Pharmabiz
Janssen: UK MHRA grants marketing approval for JanssenCilag's Lazertinib for use in combination with amivantamab to treat adults with nonsmall cell lung cancer
Jan 14, 2025
RTTNews
Janssen: ORIC Pharma Stock Climbs On Clinical Supply Deal With J&J's Janssen For ORIC-114
Jan 02, 2025
The Business Journals: Raleigh/Durham
Janssen: Pharma giant secures land for billion-dollar expansion in North Carolina
Dec 18, 2024
GlobalNewswire
Press Release: Janssen : Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant
Dec 16, 2024
Korea Biomedical Review
Janssen: SK plasma to exclusively distribute Janssen's blood cancer drug Velcade in Korea
Nov 15, 2024
FinanzNachrichten
Janssen: CHMP Recommends Janssen's Rybrevant + Lazcluze For EGFR-mutated Advanced Non-small Cell Lung Cancer
Oct 29, 2024
BioPharma-Reporter
Janssen: EC approves Janssen's Darzalex-SC combo for multiple myeloma
Oct 15, 2024
PR Newswire
Press Release: Janssen : Nipocalimab demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study
Oct 11, 2024
Pharamceutical Technology
Janssen: XtalPi's AI biologics discovery platform licensed to Janssen Biotech
Oct 01, 2024
The Business Journals
Janssen: Johnson & Johnson subsidiary to build 400-job, $1 billion plant in NC
Janssen Competitors
1
2
3
4
5
6
7
8
9
10